STOCK TITAN

Alto Ingredients (NASDAQ: ALTO) swings to profit in Q4 and full-year 2025

Filing Impact
(High)
Filing Sentiment
(Neutral)
Form Type
8-K

Rhea-AI Filing Summary

Alto Ingredients reported a strong turnaround in Q4 and full-year 2025 results. For Q4 2025, net income was $21.8M, compared with a loss of $41.7M a year earlier, and Adjusted EBITDA rose to $27.9M from a loss of $7.7M. Gross profit improved to $15.2M from a gross loss. For the year ended December 31, 2025, net income reached $13.3M versus a $59.0M loss in 2024, while Adjusted EBITDA increased to $44.7M from a loss of $8.5M. Net sales were $917.9M for 2025, modestly below 2024, but profitability improved across segments. Cash was $23.4M and total borrowing availability was $102M at year-end 2025.

Positive

  • Return to profitability: Q4 2025 net income of $21.8M and full-year 2025 net income of $13.3M represent a sharp improvement from 2024 net losses.
  • Stronger margins and cash credits: Q4 2025 Adjusted EBITDA improved to $27.9M, aided by higher crush margins, $7.5M in transferable tax credits and $6.7M in excess insurance proceeds.

Negative

  • None.

Insights

Alto delivers a sizable profitability turnaround in 2025 driven by margin and credit benefits.

Alto Ingredients shifted from sizable losses to profit in both Q4 and full-year 2025. Q4 net income of $21.8M and Adjusted EBITDA of $27.9M compare with losses a year earlier, helped by stronger crush margins, transferable tax credits and excess insurance proceeds.

For 2025, net income of $13.3M and Adjusted EBITDA of $44.7M mark a major improvement from 2024 losses, even though net sales dipped to $917.9M from $965.3M. Segment data show Western production moving from deep losses toward breakeven and positive contribution.

On the balance sheet, cash declined to $23.4M at December 31, 2025, but total liabilities fell, and stockholders’ equity increased to $245.2M. Investors may focus on whether higher-margin mix, essential ingredients returns above 50%, and monetization of $7.5M in transferable tax credits can be sustained in future periods.

false 0000778164 DE 0000778164 2026-03-04 2026-03-04 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): March 4, 2026

 

ALTO INGREDIENTS, INC.

 

(Exact Name of Registrant as Specified in Charter)

 

Delaware   000-21467   41-2170618
(State or Other Jurisdiction
of Incorporation)
  (Commission File Number)   (IRS Employer
Identification No.)

 

1300 South Second Street

Pekin, Illinois

  61554
(Address of Principal Executive Offices)   (Zip Code)

 

Registrant’s Telephone Number, Including Area Code: (833) 710-2586

 

 

 

(Former Name or Former Address, if Changed Since Last Report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

Pre-commencement communication pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
Common Stock, $0.001 par value   ALTO  

The Nasdaq Stock Market LLC

(Nasdaq Capital Market)

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).

 

Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

 

 

 

 

Item 2.02. Results of Operations and Financial Condition.

 

On March 4, 2026, Alto Ingredients, Inc. issued a press release announcing certain results of operations for the three and twelve months ended December 31, 2025. A copy of the press release is furnished (not filed) as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference.

 

The information furnished in this Item 2.02 of this Current Report on Form 8-K and Exhibit 99.1 attached hereto shall not be deemed “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section. The information in this Item 2.02 of this Current Report on Form 8-K is not incorporated by reference into any filings of Alto Ingredients, Inc. made under the Securities Act of 1933, as amended, or the Exchange Act, whether made before or after the date of this Current Report on Form 8-K, regardless of any general incorporation language in the filing unless specifically stated so therein.

 

Item 9.01. Financial Statements and Exhibits.

 

(d) Exhibits.

 

Number   Description
99.1   Press Release dated March 4, 2026
104   Cover Page Interactive Data File (formatted as Inline XBRL)

 

1

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Date: March 4, 2026 ALTO INGREDIENTS, INC.
     
  By: /S/ AUSTE M. GRAHAM
    Auste M. Graham,
    Chief Legal Officer and Secretary

 

2

 

Exhibit 99.1

 

 

Alto Ingredients, Inc. Reports Fourth Quarter and Year-end 2025 Results

 

- Results Improved in All Segments -

 

- Q4 2025 Gross Profit of $15.2 Million Increased $16.6 Million,
Q4 2025 Net Income of $21.5 Million, or $0.28 per Share, Improved $63.5 Million, and
Q4 2025 Adjusted EBITDA of $27.9 Million Grew $35.6 Million Compared to Q4 2024 -

 

Pekin, Ill., March 4, 2026 – Alto Ingredients, Inc. (NASDAQ: ALTO), a leading producer and distributor of specialty alcohols, renewable fuels and essential ingredients, reported its financial results for the quarter and year ended December 31, 2025.

 

President and Chief Executive Officer Bryon McGregor commented, “The fourth quarter capped a year of strong execution and marked a pivotal milestone in our strategic realignment. Over the course of 2025, we completed the heavy lifting of addressing losses at underperforming assets, removing structural costs and repositioning our portfolio toward higher-value and more consistent revenue streams, and we are moving forward with plans to improve our return on assets.

 

“For the fourth quarter, gross profit reached $15.2 million, an increase of $16.6 million; net income was $21.5 million, improving $63.5 million; and Adjusted EBITDA was $27.9 million, increasing $35.6 million, compared to the prior-year period. Higher crush margins, generating qualified 45Z credits and strong renewable fuel export sales were major contributors to improved performance for the quarter.”

 

Mr. McGregor continued, “We entered 2026 in a position of greater strength, with a leaner cost structure, an improved ability to navigate market volatility and a clearer strategy to drive higher-margin diversification and enhance asset values. During the year, we intend to stay focused on driving profitability and executing on opportunities to grow earnings, including enhancing and expanding our production capabilities, increasing renewable fuel exports, leveraging the demand for liquid CO2, and monetizing additional 45Z tax credits. As in 2025, we will maintain strong cost discipline and prioritize the highest ROI projects. I am proud of the progress our team has made and excited about the path forward.”

 

Financial Results for the Three Months Ended December 31, 2025 Compared to 2024

 

Net sales were $232.0 million, compared to $236.3 million.

 

Cost of goods sold was $216.8 million, compared to $237.7 million.

 

Gross profit was $15.2 million, compared to a gross loss of $1.4 million. Gross profit included $1.9 million of realized derivative gains, compared to losses of $3.5 million.

 

Selling, general and administrative expenses were $6.9 million, compared to $7.4 million.

 

Interest expense was $2.4 million, compared to $2.5 million.

 

 

 

 

 

Net income attributable to common stockholders was $21.5 million, or $0.28 per diluted share, compared to a net loss of $42.0 million, or $0.57 per share.

 

Adjusted EBITDA was $27.9 million, compared to negative $7.7 million.

 

Financial Results for the Twelve Months Ended December 31, 2025 Compared to 2024

 

Net sales were $917.9 million, compared to $965.3 million.

 

Cost of goods sold was $883.0 million, compared to $955.5 million.

 

Gross profit was $34.9 million, compared to $9.7 million. Gross profit included $10.7 million of realized derivative gains, compared to losses of $2.5 million.

 

Selling, general and administrative expenses were $27.2 million, compared to $29.7 million.

 

Interest expense was $10.8 million, compared to $7.6 million.

 

Net income attributable to common stockholders was $12.1 million, or $0.16 per diluted share, compared to a net loss of $60.3 million, or $0.82 per share.

 

Adjusted EBITDA was $44.7 million, compared to negative $8.5 million.

 

Cash and cash equivalents at December 31, 2025 were $23.4 million, compared to $35.5 million at December 31, 2024. The company’s borrowing availability at December 31, 2025 was $102 million, including $37 million under the company’s operating line of credit and $65 million under its term loan facility.

 

Fourth Quarter and Year-End 2025 Results Conference Call

 

Management will host a conference call at 2:00 p.m. Pacific Time / 5:00 p.m. Eastern Time on Wednesday, March 4, 2026, and will deliver prepared remarks via webcast followed by a question-and-answer session.

 

To receive a number and unique PIN by email, register here. To dial directly up to 20 minutes prior to the scheduled call time, please dial (833) 630-0017 domestically and (412) 317-1806 internationally. Alternatively, the webcast for the conference call can be accessed from Alto Ingredients’ website at www.altoingredients.com and will be available for one year.

 

Use of Non-GAAP Measures

 

Management believes that certain financial measures not in accordance with generally accepted accounting principles (“GAAP”) are useful measures of operations. The company defines Adjusted EBITDA as unaudited consolidated net income (loss) before interest expense, interest income, provision (benefit) for income taxes, asset impairments, unrealized derivative gains and losses, acquisition-related expense, excess insurance proceeds and depreciation and amortization expense. A table is provided at the end of this release that provides a reconciliation of Adjusted EBITDA to its most directly comparable GAAP measure, net income (loss). Management provides this non-GAAP measure so that investors will have the same financial information that management uses, which may assist investors in properly assessing the company’s performance on a period-over-period basis. Adjusted EBITDA is not a measure of financial performance under GAAP and should not be considered as an alternative to net income (loss) or any other measure of performance under GAAP, or to cash flows from operating, investing or financing activities as an indicator of cash flows or as a measure of liquidity. Adjusted EBITDA has limitations as an analytical tool, and you should not consider this measure in isolation or as a substitute for analysis of the company’s results as reported under GAAP.

 

2

 

 

 

About Alto Ingredients, Inc.

 

Alto Ingredients, Inc. (NASDAQ: ALTO) is a leading producer and distributor of specialty alcohols, renewable fuels and essential ingredients. Leveraging the unique qualities of its facilities, the company serves customers in a wide range of consumer and commercial products in the Health, Home & Beauty; Food & Beverage; Industry & Agriculture; Essential Ingredients; and Renewable Fuels markets. For more information, please visit www.altoingredients.com.

 

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995

 

Statements and information contained in this communication that refer to or include Alto Ingredients’ estimated or anticipated future results or other non-historical expressions of fact are forward-looking statements that reflect Alto Ingredients’ current perspective of existing trends and information as of the date of the communication. Forward-looking statements generally will be accompanied by words such as “anticipate,” “believe,” “plan,” “could,” “should,” “estimate,” “expect,” “forecast,” “outlook,” “guidance,” “intend,” “may,” “might,” “will,” “possible,” “potential,” “predict,” “project,” or other similar words, phrases or expressions. Such forward-looking statements include, but are not limited to, statements concerning Alto Ingredients’ expectations of driving profitability and executing on opportunities to grow earnings, including enhancing and expanding its production capabilities, increasing renewable fuel exports, leveraging the demand for liquid CO2, and monetizing additional 45Z tax credits, including the Section 45Z tax credits for which Alto Ingredients may be eligible to apply and receive; Alto Ingredients’ intentions with respect to cost discipline and prioritizing highest return on investment projects; and Alto Ingredients’ other plans, objectives, expectations and intentions. It is important to note that Alto Ingredients’ plans, objectives, expectations and intentions are not predictions of actual performance. Actual results may differ materially from Alto Ingredients’ current expectations depending upon a number of factors affecting Alto Ingredients’ business and plans. These factors include, among others adverse economic and market conditions, including for renewable fuels, specialty alcohols and essential ingredients; export conditions and international demand for the company’s products; fluctuations in the price of and demand for oil and gasoline; raw material costs, including production input costs, such as corn and natural gas; adverse impacts of inflation and supply chain constraints, including from tariffs; Alto Ingredients’ ability to timely and fully realize the results of its productivity and cost saving initiatives; regulatory developments and Alto Ingredients’ ability to successfully pursue and secure opportunities, and realize the expected results, under existing and new legislation, including the Section 45Z regulations, and to successfully apply for and receive anticipated credit amounts. These factors also include, among others, the inherent uncertainty associated with financial and other projections; the anticipated size of the markets and continued demand for Alto Ingredients’ products; the impact of competitive products and pricing; the risks and uncertainties normally incident to the alcohol production, marketing and distribution industries; changes in generally accepted accounting principles; successful compliance with governmental regulations applicable to Alto Ingredients’ facilities, products and/or businesses; changes in laws, regulations and governmental policies; the loss of key senior management or staff; and other events, factors and risks previously and from time to time disclosed in Alto Ingredients’ filings with the Securities and Exchange Commission including, specifically, those factors set forth in the “Risk Factors” section contained in Alto Ingredients’ Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on November 7, 2025.

 

Company IR and Media Contact:

 

Michael Kramer, Alto Ingredients, Inc., 916-403-2755

Investorrelations@altoingredients.com

 

IR Agency Contact:

 

Harriet Fried, Alliance Advisors Investor Relations, 212-838-3777,

Investorrelations@altoingredients.com 

 

3

 

 

 

ALTO INGREDIENTS, INC.
CONSOLIDATED STATEMENTS OF OPERATIONS

(unaudited, in thousands, except per share data)

 

   Three Months Ended
December 31,
   Years Ended
December 31,
 
   2025   2024   2025   2024 
                 
Net sales  $231,965   $236,347   $917,927   $965,258 
Cost of goods sold   216,802    237,738    883,014    955,536 
Gross profit (loss)   15,163    (1,391)   34,913    9,722 
Selling, general and administrative expenses   (6,873)   (7,358)   (27,208)   (29,736)
Acquisition-related recoveries (expenses)       (5,676)   460    (7,701)
Gain on sale of assets               830 
Asset impairments   (803)   (24,790)   (803)   (24,790)
Income (loss) from operations   7,487    (39,215)   7,362    (51,675)
Interest expense, net   (2,425)   (2,474)   (10,765)   (7,644)
Transferable tax credits, net   7,500        7,500     
Excess insurance proceeds   6,688        6,688     
Other income, net   1,935    150    1,932    508 
Income (loss) before (benefit) provision for income taxes   21,185    (41,539)   12,717    (58,811)
(Benefit) provision for income taxes   (621)   173    (621)   173 
Net income (loss)  $21,806   $(41,712)  $13,338   $(58,984)
Preferred stock dividends  $(319)  $(319)  $(1,265)  $(1,269)
Net income (loss) attributable to common stockholders  $21,487   $(42,031)  $12,073   $(60,253)
Net income (loss) per share, basic  $0.29   $(0.57)  $0.16   $(0.82)
Net income (loss) per share, diluted  $0.28   $(0.57)  $0.16   $(0.82)
Weighted-average shares outstanding, basic   74,778    73,835    74,507    73,482 
Weighted-average shares outstanding, diluted   76,536    73,835    75,663    73,482 

 

4

 

 

 

ALTO INGREDIENTS, INC.
CONSOLIDATED BALANCE SHEETS
(unaudited, in thousands, except par value)

 

ASSETS  December 31, 2025   December 31, 2024 
Current Assets:        
Cash and cash equivalents  $23,415   $35,469 
Restricted cash   2,258    742 
Accounts receivable, net   55,069    58,217 
Inventories   61,676    49,914 
Derivative instruments   525    3,313 
Transferable tax credits, net   7,500     
Other current assets   5,474    5,463 
Total current assets   155,917    153,118 
Property and equipment, net   198,501    214,742 
Other Assets:          
Right of use operating lease assets, net   16,931    20,553 
Intangible assets, net   7,574    4,509 
Other assets   9,863    8,516 
Total other assets   34,368    33,578 
Total Assets  $388,786   $401,438 

 

5

 

 

 

ALTO INGREDIENTS, INC.
CONSOLIDATED BALANCE SHEETS (CONTINUED)
(unaudited, in thousands, except par value)

 

LIABILITIES AND STOCKHOLDERS’ EQUITY  December 31,
2025
   December 31,
2024
 
Current Liabilities:        
Accounts payable  $14,509   $20,369 
Accrued liabilities   16,691    24,214 
Current portion – long-term debt   16,600     
Current portion – operating leases   4,958    4,851 
Derivative instruments   1,067    1,177 
Other current liabilities   5,246    7,193 
Total current liabilities   59,071    57,804 
           
Long-term debt, net   63,027    92,904 
Operating leases, net of current portion   13,012    16,913 
Other liabilities   8,435    8,754 
Total Liabilities   143,545    176,375 
           
Stockholders’ Equity:          
Preferred stock, $0.001 par value; 10,000 shares authorized; Series A: no shares issued and outstanding as of December 31, 2025 and 2024 Series B: 927 shares issued and outstanding as of December 31, 2025 and 2024   1    1 
Common stock, $0.001 par value; 300,000 shares authorized; 77,307 and 76,565 shares issued and outstanding as of December 31, 2025 and 2024, respectively   77    77 
Non-voting common stock, $0.001 par value; 3,553 shares authorized; 1 share issued and outstanding as of December 31, 2025 and 2024        
Additional paid-in capital   1,051,795    1,044,176 
Accumulated other comprehensive income   5,461    4,975 
Accumulated deficit   (812,093)   (824,166)
Total Stockholders’ Equity   245,241    225,063 
Total Liabilities and Stockholders’ Equity  $388,786   $401,438 

 

6

 

 

 

Reconciliation of Adjusted EBITDA to Net Income (Loss)

 

   Three Months Ended
December 31,
   Years Ended
December 31,
 
(in thousands) (unaudited)  2025   2024   2025   2024 
Net income (loss)  $21,806   $(41,712)  $13,338   $(58,984)
Adjustments:                    
Interest expense, net   2,425    2,474    10,765    7,644 
Interest income   (175)   (112)   (381)   (689)
Unrealized derivative (gains) losses   4,036    (5,495)   2,679    (13,574)
Excess insurance proceeds   (6,688)       (6,688)    
Acquisition-related expenses (recoveries)       5,676    (460)   7,701 
(Benefit) provision for income taxes   (621)   173    (621)   173 
Asset impairments   803    24,790    803    24,790 
Depreciation and amortization expense   6,328    6,548    25,216    24,408 
Total adjustments   6,108    34,054    31,313    50,453 
Adjusted EBITDA  $27,914   $(7,658)  $44,651   $(8,531)

 

7

 

 

 

Segment Financials (unaudited, in thousands)

 

   Three Months Ended
December 31,
   Years Ended
December 31,
 
   2025   2024   2025   2024 
Net Sales                
Pekin Campus, recorded as gross:                
Alcohol sales  $105,134   $100,216   $415,801   $415,710 
Essential ingredient sales   45,108    42,011    174,598    169,308 
Intersegment sales   324    316    1,088    1,243 
Total Pekin Campus sales   150,566    142,543    591,487    586,261 
Marketing and distribution:                    
Alcohol sales, gross  $55,398   $37,290   $221,306   $216,524 
Intersegment sales   2,489    2,831    9,827    10,833 
Total marketing and distribution sales   57,887    40,121    231,133    227,357 
                     
Western production, recorded as gross:                    
Alcohol sales  $17,083   $41,306   $67,301   $115,389 
Essential ingredient sales   7,476    12,769    31,552    36,953 
Intersegment sales   416        1,697    (122)
Total Western production sales   24,975    54,075    100,550    152,220 
                     
Corporate and other   1,766    2,755    7,369    11,374 
Intersegment eliminations   (3,229)   (3,147)   (12,612)   (11,954)
Net sales as reported  $231,965   $236,347   $917,927   $965,258 
                     
Cost of goods sold :                    
Pekin Campus (1) (2)  $139,712   $139,899   $572,134   $563,033 
Marketing and distribution   53,190    36,348    214,095    213,023 
Western production (1)   24,931    59,449    96,897    172,209 
Corporate and other   1,240    3,592    6,689    12,285 
Intersegment eliminations   (2,271)   (1,550)   (6,801)   (5,014)
Cost of goods sold as reported  $216,802   $237,738   $883,014   $955,536 
                     
Gross profit (loss):                    
Pekin Campus  $10,854   $2,644   $19,353   $23,228 
Marketing and distribution   4,697    3,773    17,038    14,334 
Western production   44    (5,374)   3,653    (19,989)
Corporate and other   526    (837)   680    (911)
Intersegment eliminations   (958)   (1,597)   (5,811)   (6,940)
Gross profit (loss) as reported  $15,163   $(1,391)  $34,913   $9,722 

 

 

(1)includes depreciation and amortization expense
(2)includes unrealized gain (loss) on derivatives

 

8

 

 

 

Sales and Operating Metrics (unaudited)

 

   Three Months Ended
December 31,
   Years Ended
December 31,
 
   2025   2024   2025   2024 
Alcohol Sales (gallons in millions)                
Pekin Campus renewable fuel gallons sold   29.5    32.1    122.6    125.7 
Western production renewable fuel gallons sold   7.9    22.3    32.6    60.5 
Third party renewable fuel gallons sold   25.7    19.0    106.9    108.3 
Total renewable fuel gallons sold   63.1    73.4    262.1    294.5 
Specialty alcohol gallons sold   21.4    21.7    88.0    91.5 
Total gallons sold   84.5    95.1    350.1    386.0 
                     
Sales Price per Gallon                    
Pekin Campus  $2.09   $1.89   $2.00   $1.95 
Western production  $2.16   $1.86   $2.06   $1.91 
Marketing and distribution  $2.15   $1.96   $2.07   $2.00 
Total  $2.10   $1.88   $2.02   $1.95 
                     
Alcohol Production (gallons in millions)                    
Pekin Campus   54.5    55.4    215.3    212.4 
Western production   8.1    21.2    32.9    58.7 
Total   62.6    76.6    248.2    271.1 
                     
Corn Cost per Bushel                    
Pekin Campus  $4.22   $4.17   $4.54   $4.45 
Western production  $5.47   $5.79   $5.62   $5.73 
Total  $4.38   $4.63   $4.68   $4.72 
                     
Average Market Metrics                    
PLATTS Ethanol price per gallon  $1.77   $1.60   $1.76   $1.69 
CME Corn cost per bushel  $4.31   $4.26   $4.39   $4.24 
Board corn crush per gallons (1)  $0.23   $0.08   $0.19   $0.18 
                     
Essential Ingredients Sold (thousand tons)                    
Pekin Campus:                    
Distillers grains   85.4    85.3    337.6    336.4 
CO2   46.2    52.7    192.2    188.6 
Corn wet feed   21.2    41.4    107.3    121.8 
Corn dry feed   34.6    22.0    106.9    87.2 
Corn oil and germ   20.0    21.0    78.0    75.1 
Syrup and other   6.7    10.0    36.4    38.6 
Corn meal   9.3    9.3    36.8    35.4 
Yeast   5.9    5.4    24.4    23.2 
Total Pekin Campus essential ingredients sold   229.3    247.1    919.6    906.3 

 

9

 

 

 

   Three Months Ended
December 31,
   Years Ended
December 31,
 
   2025   2024   2025   2024 
Western production:                
Distillers grains   56.1    144.3    235.3    394.5 
CO2   13.5    14.6    56.5    57.7 
Syrup and other   0.8    17.2    3.5    54.8 
Corn oil   1.1    3.1    4.3    7.6 
Total Western production essential ingredients sold   71.5    179.2    299.6    514.6 
                     
Total Essential Ingredients Sold   300.8    426.3    1,219.2    1,420.9 
                     
Essential ingredients return % (2)                    
Pekin Campus return   53.1%   49.5%   49.3%   49.7%
Western production return   48.3%   30.3%   50.4%   32.0%
Consolidated total return   52.4%   43.1%   49.5%   45.2%

 

 

(1)Assumes corn conversion of 2.80 gallons of alcohol per bushel of corn.

(2)Essential ingredients revenues as a percentage of total corn costs consumed.

 

####

 

10

 

FAQ

How did Alto Ingredients (ALTO) perform in Q4 2025?

Alto Ingredients posted a solid Q4 2025 turnaround, earning net income of $21.8 million. Adjusted EBITDA reached $27.9 million, compared with a loss a year earlier, while gross profit improved to $15.2 million as margins strengthened across key segments.

What were Alto Ingredients’ full-year 2025 financial results?

For 2025, Alto Ingredients generated $13.3 million in net income, reversing a prior-year loss. Adjusted EBITDA improved to $44.7 million from a negative result, on net sales of $917.9 million, reflecting better profitability despite slightly lower revenue than 2024.

How did Alto Ingredients’ revenue in 2025 compare to 2024?

Net sales for 2025 were $917.9 million, modestly below the $965.3 million reported in 2024. Despite this decline, the company significantly improved profitability, supported by higher crush margins, stronger renewable fuel exports and more profitable segment performance.

What is Alto Ingredients’ cash and debt position at year-end 2025?

At December 31, 2025, cash and cash equivalents were $23.4 million. Total borrowing availability was $102 million, including an operating line of credit and term loan facility, while total liabilities decreased and stockholders’ equity rose to $245.2 million.

How did Alto Ingredients’ segments contribute to 2025 results?

In 2025, Pekin Campus and marketing and distribution generated positive gross profit, while Western production improved from prior losses. Consolidated gross profit rose to $34.9 million, compared with $9.7 million in 2024, indicating better performance across operating segments.

What non-GAAP measure does Alto Ingredients emphasize?

Alto Ingredients highlights Adjusted EBITDA as a key non-GAAP performance metric. It adjusts net income for interest, taxes, depreciation, amortization, impairments, derivatives, acquisition items and certain proceeds, aiming to show operational performance trends beyond GAAP net income volatility.

Filing Exhibits & Attachments

4 documents
Alto Ingredients Inc

NASDAQ:ALTO

ALTO Rankings

ALTO Latest News

ALTO Latest SEC Filings

ALTO Stock Data

310.92M
71.76M
Specialty Chemicals
Industrial Organic Chemicals
Link
United States
SACRAMENTO